FDMT

4D Molecular Therapeutics Inc.

16.05

+0.81+5.32%

Opening13:21 09/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE15.21/15.24

TODAY RANGE15.16-16.18

VOL342.41K

MARKET CAP886.67M

52 WEEK RANGE6.47-16.93

AVG VOL (3M)937.55K

% TURNOVER0.62%

TURNOVER--

P/E (TTM)-5.8194

% RANGE6.69%

EPS(TTM)-2.7580

P/E(FORWARD)-3.9146

P/B2.174

BVPS7.38

DIVIDEND--

P/S10.85

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP861.60M

SHARES OUTSTANDING55.24M

NEXT EARNINGS11/09-11/13

FREE FLOAT53.68M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Recursion Pharmaceuticals (RXRX) and Contineum Therapeutics, Inc. Class A (CTNM)
TipRanks·5d ago
4D Molecular management to meet with B. Riley
Dow Jones·09/14 11:12
4D Molecular Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald
Dow Jones·09/14 11:12
4D Molecular Therapeutics Price Target Announced at $20.00/Share by Cantor Fitzgerald
TipRanks·09/14 10:40
4D Molecular upgraded to Overweight from Neutral at Cantor Fitzgerald
TipRanks·09/14 01:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·08/17 18:15
B. Riley views EyePoint study miss as positive for 4D Molecular
TipRanks·08/14 15:20
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)
TipRanks·08/14 13:00
Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)
TipRanks·08/14 12:37
RBC Capital Remains a Buy on 4D Molecular Therapeutics (FDMT)
TipRanks·08/14 12:17
Cantor Fitzgerald Reaffirms Their Hold Rating on 4D Molecular Therapeutics (FDMT)
TipRanks·08/14 10:35
Analyst Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target as 4D-150 Advances Through Late-Stage Trials
NASDAQ·08/13 22:05
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates
NASDAQ·08/13 12:15
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
Dow Jones·07/31 16:02
4D Molecular Therapeutics Price Target Announced at $37.00/Share by B. Riley Securities

Same Industry

Name/Symbol

Change%

Price

FDMT

Regeneron Pharmaceuticals

REGN

-0.58%

784.85

GridAI Tech

GRDX

+9.32%

3.400

BNTX

United Therapeutics Corp.

UTHR

+0.65%

496.31

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

-2.55%

154.04

CRL

MEDP

TLPH

CBPO

ICON plc

ICLR

-3.28%

164.11

Iqvia Hldgs Inc

IQV

+1.30%

269.88

MOLN

ARCT

Gilead Sciences Inc

GILD

-0.52%

150.11

PRAH

Incyte Corp

INCY

-1.81%

125.31

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.